Correlation Between ESSA Pharma and HUTCHMED DRC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ESSA Pharma and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ESSA Pharma and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ESSA Pharma and HUTCHMED DRC, you can compare the effects of market volatilities on ESSA Pharma and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ESSA Pharma with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of ESSA Pharma and HUTCHMED DRC.

Diversification Opportunities for ESSA Pharma and HUTCHMED DRC

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between ESSA and HUTCHMED is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding ESSA Pharma and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and ESSA Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ESSA Pharma are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of ESSA Pharma i.e., ESSA Pharma and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between ESSA Pharma and HUTCHMED DRC

Given the investment horizon of 90 days ESSA Pharma is expected to under-perform the HUTCHMED DRC. In addition to that, ESSA Pharma is 3.12 times more volatile than HUTCHMED DRC. It trades about -0.12 of its total potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.05 per unit of volatility. If you would invest  1,650  in HUTCHMED DRC on September 23, 2024 and sell it today you would lose (219.00) from holding HUTCHMED DRC or give up 13.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

ESSA Pharma  vs.  HUTCHMED DRC

 Performance 
       Timeline  
ESSA Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
HUTCHMED DRC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

ESSA Pharma and HUTCHMED DRC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ESSA Pharma and HUTCHMED DRC

The main advantage of trading using opposite ESSA Pharma and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ESSA Pharma position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.
The idea behind ESSA Pharma and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences